Avadel Pharma (AVDL) Misses Q2 EPS by 65c

Avadel Pharma (NASDAQ: AVDL) reported Q2 EPS of ($1.07), $0.65 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• Qualcomm investor day to detail data center plans Wednesday
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI